0000000000366715

AUTHOR

R Popescu

showing 2 related works from this author

Association between antithrombotic treatment and outcomes at 1-year follow-up in patients with atrial fibrillation: the EORP-AF General Long-Term Reg…

2019

Aims In recent years, stroke prevention in patients with atrial fibrillation (AF) has radically changed, with increasing use of non-vitamin K antagonist oral anticoagulants (NOACs). Contemporary European data on AF thromboprophylaxis are needed. Methods and results We report 1-year follow-up data from the EURObservational Research Programme in Atrial Fibrillation (EORP-AF) General Long-Term Registry. Outcomes were assessed according to antithrombotic therapy. At 1-year follow-up, 9663 (88.0%) patients had available data for analysis: 586 (6.1%) were not treated with any antithrombotic; 681 (7.0%) with antiplatelets only; 4066 (42.1%) with vitamin K antagonist (VKA) only; 3167 (32.8%) with …

AdultMaleAcute coronary syndromemedicine.medical_specialtymedicine.drug_classHemorrhageOutcomes030204 cardiovascular system & hematologyLower riskRisk Assessment[SHS]Humanities and Social Sciences03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRisk FactorsPhysiology (medical)Internal medicineCause of DeathAntithromboticMedicineHumans030212 general & internal medicineProspective StudiesRegistriesPractice Patterns Physicians'StrokeAgedEORP-AF registryAged 80 and overAntithrombotic therapybusiness.industryProportional hazards modelAtrial fibrillationVitamin K antagonistMiddle Agedmedicine.diseaseAtrial fibrillationObservational registriesEuropeStrokeFemaleCardiology and Cardiovascular MedicinebusinessAntithrombotic therapy; Atrial fibrillation; EORP-AF registry; Observational registries; Outcomes; StrokeFibrinolytic agentFollow-Up Studies
researchProduct

Performance of the ATLAS detector using first collision data

2010

More than half a million minimum-bias events of LHC collision data were collected by the ATLAS experiment in December 2009 at centre-of-mass energies of 0.9 TeV and 2.36 TeV. This paper reports on studies of the initial performance of the ATLAS detector from these data. Comparisons between data and Monte Carlo predictions are shown for distributions of several track- and calorimeter-based quantities. The good performance of the ATLAS detector in these first data gives confidence for successful running at higher energies.

Nuclear and High Energy PhysicsParticle physicsAtlas detectorPhysics::Instrumentation and DetectorsMonte Carlo methodFOS: Physical sciencesddc:500.253001 natural sciences7. Clean energySettore FIS/04 - Fisica Nucleare e SubnucleareHigh Energy Physics - ExperimentNuclear physicsHigh Energy Physics - Experiment (hep-ex)LHC ; ATLAS ; Minimum-bias ; 900 GeV ; 2.36 TeV ; PerformanceAtlas (anatomy)0103 physical sciencesmedicine[PHYS.HEXP]Physics [physics]/High Energy Physics - Experiment [hep-ex]ddc:530High Energy PhysicsDetectors and Experimental Techniques010306 general physicsCiencias ExactasDetectors de radiacióPhysicsHadron-Hadron ScatteringLarge Hadron Collider010308 nuclear & particles physicsATLAS DetectorSettore FIS/01 - Fisica SperimentaleATLAS experimentFísicaATLASCollisionmedicine.anatomical_structureExperimental High Energy PhysicsComputingMethodologies_DOCUMENTANDTEXTPROCESSINGHigh Energy Physics::ExperimentLHCParticle Physics - Experiment
researchProduct